Stati Uniti - inglese - NLM (National Library of Medicine)

bryant ranch prepack - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine maleate capsules are indicated for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. in studies with neurotic outpatients, the drug appeared to be equivalent to amitriptyline in the less-depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients. in hospitalized depressed patients, trimipramine and imipramine were equally effective in relieving depression. the use of maois intended to treat psychiatric disorders with trimipramine maleate or within 14 days of stopping treatment with trimipramine maleate is contraindicated because of an increased risk of serotonin syndrome. the use of trimipramine maleate within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting trimipramine maleate in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also co

Stati Uniti - inglese - NLM (National Library of Medicine)

actavis pharma, inc. - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine 25 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

dr. reddy laboratories, inc. - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine 25 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

teva women's health, inc. - trimipramine maleate (unii: 269k6498ld) (trimipramine - unii:6s082c9ndt) - trimipramine 25 mg - surmontil is indicated for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. in studies with neurotic outpatients, the drug appeared to be equivalent to amitriptyline in the less-depressed patients but somewhat less effective than amitriptyline in the more severely depressed patients. in hospitalized depressed patients, trimipramine and imipramine were equally effective in relieving depression. the use of maois intended to treat psychiatric disorders with surmontil or within 14 days of stopping treatment with surmontil is contraindicated because of an increased risk of serotonin syndrome. the use of surmontil within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting surmontil in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (

Canada - inglese - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 12.5mg - trimipramine (trimipramine maleate) 12.5mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - inglese - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 25mg - trimipramine (trimipramine maleate) 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - inglese - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 50mg - trimipramine (trimipramine maleate) 50mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - inglese - Health Canada

apotex inc - trimipramine (trimipramine maleate) - tablet - 100mg - trimipramine (trimipramine maleate) 100mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - inglese - Health Canada

apotex inc - trimipramine (trimipramine maleate) - capsule - 75mg - trimipramine (trimipramine maleate) 75mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - inglese - Health Canada

aa pharma inc - trimipramine (trimipramine maleate) - tablet - 12.5mg - trimipramine (trimipramine maleate) 12.5mg - tricyclics and other norepinephrine-reuptake inhibitors